Tzvika Porges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tzvika Porges has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Lior Zeller
Ben Gurion Univ Negev, Soroka Univ, Fac Hlth Sci, Dept Internal Med C,Med Ctr, IL-84101 Beer Sheva, Israel
2 shared publications - Amir Bieber
Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
1 shared publication - Bruce Guthrie
Advanced Care Research Centre, Usher Institute, University of Edinburgh, Edinburgh, UK
1 shared publication - Clare MacRae
Advanced Care Research Centre, University of Edinburgh, Edinburgh, UK
1 shared publication - David Weller
Advanced Care Research Centre, Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh
1 shared publication Elli Rosenberg
Clinical Immunology Clinic, Soroka University Medical Center, Beer Sheva, Israel
1 shared publication
Latest Publications
- 16 November 2024
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (12) , 5935-5939
Case report: VEXAS syndrome with excellent response to treatment with azacitidine
Vacuoles, E1 enzyme, X-linked, auto inflammatory, somatic (VEXAS) syndrome is an inflammatory disorder caused by somatic UBA1 variants and is characterized by late-onset systemic autoimmune inflammation and blood abnormalities. Glucocorticoids ameliorate symptoms effectively. However, other treatment options have limited efficacy and a transient effect. Herein, we describe a case of a 69-year-old male patient with VEXAS syndrome with skin, lung and hematologic involvement. He was treated with glucocorticoids and after the failure with anti IL-1 he began treatment with azacitidine with excellent hematological and clinical response. Azacitidine may be a suitable option for treating VEXAS syndrome, especially due to the relationship between inflammatory symptoms and response to azacitidine.
- 16 November 2024
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (12) , 5935-5939
Case report: VEXAS syndrome with excellent response to treatment with azacitidine
Vacuoles, E1 enzyme, X-linked, auto inflammatory, somatic (VEXAS) syndrome is an inflammatory disorder caused by somatic UBA1 variants and is characterized by late-onset systemic autoimmune inflammation and blood abnormalities. Glucocorticoids ameliorate symptoms effectively. However, other treatment options have limited efficacy and a transient effect. Herein, we describe a case of a 69-year-old male patient with VEXAS syndrome with skin, lung and hematologic involvement. He was treated with glucocorticoids and after the failure with anti IL-1 he began treatment with azacitidine with excellent hematological and clinical response. Azacitidine may be a suitable option for treating VEXAS syndrome, especially due to the relationship between inflammatory symptoms and response to azacitidine.
- Open Access
- 27 July 2023
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 73 (733) , 373-376
Defining and measuring complex multimorbidity: a critical analysis
Multimorbidity is important for many reasons. For the patient, increasing levels of multimorbidity reduce quality of life and increase mortality, and can place severe financial and other strains (such as treatment burden) on individuals and families.3 Healthcare practitioners often struggle to cope with the complex needs of multimorbid patients,3 and the evidence base for interventions in multimorbid patients is sparse.4 Multimorbidity places pressure on the healthcare system, with higher utilisation of care services.3 Multimorbidity increases in prevalence with age, and also with worsening socioeconomic status, with poorer patients developing multimorbidity at a much earlier age than the well- off.5 Multimorbidity is not only the norm rather than the exception in high-income countries, but is also of growing importance in low- and middle-income countries.6 Thus, understanding multimorbidity better and developing better ways to identify and treat the most vulnerable patients is of key concern globally.
- 27 July 2023
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 73 (733) , 373-376
Open AccessDefining and measuring complex multimorbidity: a critical analysis
Multimorbidity is important for many reasons. For the patient, increasing levels of multimorbidity reduce quality of life and increase mortality, and can place severe financial and other strains (such as treatment burden) on individuals and families.3 Healthcare practitioners often struggle to cope with the complex needs of multimorbid patients,3 and the evidence base for interventions in multimorbid patients is sparse.4 Multimorbidity places pressure on the healthcare system, with higher utilisation of care services.3 Multimorbidity increases in prevalence with age, and also with worsening socioeconomic status, with poorer patients developing multimorbidity at a much earlier age than the well- off.5 Multimorbidity is not only the norm rather than the exception in high-income countries, but is also of growing importance in low- and middle-income countries.6 Thus, understanding multimorbidity better and developing better ways to identify and treat the most vulnerable patients is of key concern globally.
- 13 September 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (12) , 2261-2266
New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review
Emerging data evaluated the possible link between the Coronavirus 19 (COVID-19) vaccine and acute flares of rheumatic autoimmune diseases. However, the association between the COVID-19 vaccine and the development of de-novo rheumatic autoimmune diseases remained unclear. We report the first case series of three male patients who developed new-onset systemic lupus erythematosus following receiving Pfizer BNT162b2 mRNA vaccination. The clinical characteristics share some similarities with drug-induced lupus. More patients with SLE following COVID-19 may be diagnosed in the future. Additional studies will provide more significant insights into the possible immunogenic influence of the COVID-19 vaccine.
- 13 September 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (12) , 2261-2266
New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review
Emerging data evaluated the possible link between the Coronavirus 19 (COVID-19) vaccine and acute flares of rheumatic autoimmune diseases. However, the association between the COVID-19 vaccine and the development of de-novo rheumatic autoimmune diseases remained unclear. We report the first case series of three male patients who developed new-onset systemic lupus erythematosus following receiving Pfizer BNT162b2 mRNA vaccination. The clinical characteristics share some similarities with drug-induced lupus. More patients with SLE following COVID-19 may be diagnosed in the future. Additional studies will provide more significant insights into the possible immunogenic influence of the COVID-19 vaccine.
- Open Access
- 29 April 2021
- Published by University Library System, University of Pittsburgh in International Journal of Medical Students
- Vol. 9 (1) , 15-20
Case series: Point-of-Care Ultrasound Conducted by Medical Students During their First Clinical Rotation Changes Patients’ Primary Diagnosis and Management
Background: As point-of-care ultrasound (POCUS) becomes a standard of care procedure, medical schools around the world have started to seek the integration of POCUS courses into their curricula. This puts medical students in a unique position as they are trained in an area in which many physicians lack knowledge. This case series provides a glimpse into the capabilities of POCUS even when used by medical students. Methods: Fourth-year medical students at Ben-Gurion University of the Negev performed numerous POCUS exams during their first clinical rotation at Soroka University Medical Center in Israel. All students completed a course in basic POCUS training and were evaluated in a brief practical exam before entering their first clinical rotation. Four of the cases in which the students took part are presented in this case series. Results: The POCUS exam in the first case discovered pulmonary embolism in addition to the diagnosis of Cushing disease. In the second case, endocarditis could have been diagnosed three days earlier had a POCUS exam been performed. Case 3 demonstrates the additional contribution of POCUS to the decision-making process carried out by physicians and its superiority in quantifying and diagnosing pleural effusion compared to chest X-Ray. Case 4 indicated that POCUS is preferable over chest X-ray and auscultation for the diagnosis of pulmonary edema. Conclusion: This case series may emphasize the capabilities POCUS has when utilized in the standard physical examination and the importance of incorporating POCUS instruction in medical schools for new physicians to acquire this skill.
- 29 April 2021
- Published by University Library System, University of Pittsburgh in International Journal of Medical Students
- Vol. 9 (1) , 15-20
Open AccessCase series: Point-of-Care Ultrasound Conducted by Medical Students During their First Clinical Rotation Changes Patients’ Primary Diagnosis and Management
Background: As point-of-care ultrasound (POCUS) becomes a standard of care procedure, medical schools around the world have started to seek the integration of POCUS courses into their curricula. This puts medical students in a unique position as they are trained in an area in which many physicians lack knowledge. This case series provides a glimpse into the capabilities of POCUS even when used by medical students. Methods: Fourth-year medical students at Ben-Gurion University of the Negev performed numerous POCUS exams during their first clinical rotation at Soroka University Medical Center in Israel. All students completed a course in basic POCUS training and were evaluated in a brief practical exam before entering their first clinical rotation. Four of the cases in which the students took part are presented in this case series. Results: The POCUS exam in the first case discovered pulmonary embolism in addition to the diagnosis of Cushing disease. In the second case, endocarditis could have been diagnosed three days earlier had a POCUS exam been performed. Case 3 demonstrates the additional contribution of POCUS to the decision-making process carried out by physicians and its superiority in quantifying and diagnosing pleural effusion compared to chest X-Ray. Case 4 indicated that POCUS is preferable over chest X-ray and auscultation for the diagnosis of pulmonary edema. Conclusion: This case series may emphasize the capabilities POCUS has when utilized in the standard physical examination and the importance of incorporating POCUS instruction in medical schools for new physicians to acquire this skill.